Schroder Investment Management Group
GNMK

Schroder Investment Management Group’s GenMark Diagnostics, Inc GNMK Stock Holding History

Schroder Investment Management Group’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-295,900
Closed -$3.93M – 1546
2013
Q4 		$3.93M Sell
295,900
-29,100
-9% -$353K ﹤0.01% 841
2013
Q3 		$3.95M Buy
+325,000
New +$3.48M 0.01% 806

Other funds holding GNMK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Schroder Investment Management Group's GNMK Position: Q1 2014 in Review

Schroder Investment Management Group sold out of GenMark Diagnostics, Inc (GNMK) in Q1 2014, closing a stake of 295,900 shares — an estimated $3.93M sold.

Schroder Investment Management Group first reported a position in GNMK in Q3 2013 and held it in 2 quarters. The position peaked at $3.95M in Q3 2013. 78 funds tracked by Wall St. Rank hold GNMK as of Q1 2014.

  • Schroder Investment Management Group reported no remaining GenMark Diagnostics, Inc position as of Q1 2014 after selling out during the quarter.
  • Schroder Investment Management Group sold 295,900 GenMark Diagnostics, Inc shares in Q1 2014, an estimated $3.93M.
  • Schroder Investment Management Group first reported a position in GenMark Diagnostics, Inc in Q3 2013 and held it in 2 quarters.
  • Schroder Investment Management Group's GenMark Diagnostics, Inc position peaked at $3.95M in Q3 2013.
  • 78 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q1 2014.

Based on Schroder Investment Management Group's 13F filing for Q1 2014, filed 15 May 2014.